NCT00008437
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States
- CHUM Hopital Saint-Luc Montreal, Quebec, Canada
Clinical trial condition
Breast Diseases
Explore clinical trials studying Breast Diseases. Study availability and eligibility vary by location and protocol.
10,364 public trials
1,990 recruiting studies
Breast Diseases trial results
NCT00445406
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Universitaetsspital-Basel Basel, Switzerland
NCT00717340
- Conditions
- Breast Diseases, Breast Neoplasms, Metastatic Breast Cancer, +4 more
- Locations
-
- Dana Farber Cancer Institute, Inc. Boston, Massachusetts, United States
- Memorial Sloan-Kettering Cancer Center New York, United States
- Universitaetsklinikum Essen Essen, Germany
NCT00754351
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- University Hospital of Crete, Dep of Medical Oncology Heraklion, Crete, Greece
- University General Hospital of Alexandroupolis, Dep of Medical Oncology Alexandroupoli, Greece
NCT00435409
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Pfizer Investigational Site Downey, California, United States
- Pfizer Investigational Site Fresno, California, United States
- Pfizer Investigational Site Montebello, California, United States
- Pfizer Investigational Site Whittier, California, United States
NCT00446030
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Sanofi-Aventis Administrative Office Bridgewater, New Jersey, United States
NCT00076024
- Conditions
- Breast Diseases, Breast Neoplasms, Neoplasms, +3 more
- Locations
-
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Tucson, Arizona, United States
- Pfizer Investigational Site Berkeley, California, United States
- Pfizer Investigational Site Montebello, California, United States
Completed
Phase II Neoadjuvant Trial of Trastuzumab in Combination With Dose-Dense ABI-007 (Abraxane™)
NCT00503750
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Piedmont Hospital Research Institute Atlanta, Georgia, United States
- Emory University Winship Cancer Institute Atlanta, Georgia, United States
NCT01042938
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- University of Rochester Medical Center & Wilmot Cancer Center Rochester, New York, United States
NCT00626119
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +4 more
- Locations
-
- Mayo Clinic Cancer Center Rochester, Minnesota, United States